ÂÜÀòÂÒÂ×

Marcin Kortylewski is a distinguished scientist and entrepreneur with extensive experience in the fields of molecular biology and tumor immunology. Currently, Marcin serves as a Co-Founder at Aptadir Therapeutics and Duet BioTherapeutics, while holding the position of Professor at City of Hope since May 2021. Additionally, Marcin has editorial roles at Cell Press, including Section Editor and Associate Editor-in-Chief for Molecular Therapy Nucleic Acids. Previous roles include Founder of iSTAT Therapeutics and Assistant Professor at City of Hope, alongside significant research positions at Moffitt Cancer Center and RWTH Aachen University. Marcin's educational background includes a Ph.D. in Molecular Biology from Poznan University of Medical Sciences and postdoctoral training at H. Lee Moffitt Cancer Center and RWTH Aachen University.